Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans

Aerobic Exercise Training-Induced Decrease in Plasma Visfatin and Insulin Resistance in Obese Female Adolescents

(2016) Kyu-Jin Lee et al.   INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM

Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets

(2010) Bertalan Mesko et al.   BMC Medical Genomics

Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms

(2010) S. V. de Kreutzenberg et al.   DIABETES

Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients

(2010) Young Sun Kang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages

(2010) Thérèse Hèrvée Mayi et al.   FEBS Journal

Protective Role of SIRT1 in Diabetic Vascular Dysfunction

(2009) Masayuki Orimo et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes

(2009) A. Garten et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The NAD World: A New Systemic Regulatory Network for Metabolism and Aging—Sirt1, Systemic NAD Biosynthesis, and Their Importance

(2009) Shin-ichiro Imai   CELL BIOCHEMISTRY AND BIOPHYSICS

SIRT1 and caloric restriction: an insight into possible trade-offs between robustness and frailty

(2009) Shin-ichiro Imai   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose

(2009) Dag Hofsø et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

NAMPT is essential for the G-CSF–induced myeloid differentiation via a NAD+–sirtuin-1–dependent pathway

(2009) Julia Skokowa et al.   NATURE MEDICINE

Release of 12 Adipokines by Adipose Tissue, Nonfat Cells, and Fat Cells From Obese Women

(2009) John N. Fain et al.   Obesity

Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1

(2009) Y. Nakahata et al.   SCIENCE

Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis

(2009) K. M. Ramsey et al.   SCIENCE

Adipocytes and adipose tissue

(2008) Wieland Kiess et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study

(2008) Ravi Retnakaran et al.   CLINICAL ENDOCRINOLOGY

Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus

(2008) I. Brema et al.   DIABETES OBESITY & METABOLISM

Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol

(2008) Hua Jin et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers

(2008) S. Bo et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Interdisciplinary European Guidelines on Surgery of Severe Obesity

(2008) Martin Fried et al.   Obesity Facts

Nampt: linking NAD biology, metabolism and cancer

(2008) Antje Garten et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women

(2007) Ji A Seo et al.   DIABETES RESEARCH AND CLINICAL PRACTICE